Evidence map›Paper›PMID 42786177›Full record

ArticleNature communications2026

Exosomal export of activated CASPASE-8 is linked to the prevention of TNF-induced cytotoxicity.

Jon Huyghe, Dario Priem, Annelore Haems, Lien Lippens, Margaux De Meyer, Tom Delanghe, Yves Dondelinger, Inge Bruggeman, Peter Vandenabeele, Sven Eyckerman and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jon HuygheVIB Center for Inflammation Research, Ghent, Belgium. jon.huyghe@irc.vib-ugent.be.ORCID 0000-0002-5306-5540
Dario PriemVIB Center for Inflammation Research, Ghent, Belgium.ORCID 0000-0002-2527-1101
Annelore HaemsVIB Center for Inflammation Research, Ghent, Belgium.
Lien LippensLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
Margaux De MeyerVIB-UGent Center for Medical Biotechnology, Ghent, Belgium.ORCID 0000-0002-6961-0769
Tom DelangheVIB Center for Inflammation Research, Ghent, Belgium.ORCID 0000-0002-6337-6457
Yves DondelingerVIB Center for Inflammation Research, Ghent, Belgium.
Inge BruggemanVIB Center for Inflammation Research, Ghent, Belgium.
Peter VandenabeeleVIB Center for Inflammation Research, Ghent, Belgium.ORCID 0000-0002-6669-8822
Sven EyckermanVIB-UGent Center for Medical Biotechnology, Ghent, Belgium.ORCID 0000-0001-7525-0096
An HendrixLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.ORCID 0000-0002-1883-8309
Mathieu Jm BertrandVIB Center for Inflammation Research, Ghent, Belgium. mathieu.bertrand@irc.vib-ugent.be.ORCID 0000-0001-9000-0626

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) No. 101045156Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 1192326NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 1269425NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 1270825NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 3G046420Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 3G0I5722Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G042918NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G0A7L24NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) No. S000319NUniversiteit Gent (UGent) 01G00123Universiteit Gent (UGent) 01IB3920Vlaamse Overheid (Government of Flanders) Methusalem 01M00709
6 · The paper itself

Abstract

Tumor Necrosis Factor (TNF) is a key pro-inflammatory cytokine whose sensing by TNFR1 triggers gene activation or cell death induction. While TNF cytotoxicity can be beneficial during infections by supporting effective immune responses, its chronic or excessive induction is harmful and promotes inflammatory pathologies. Protective brakes, known as cell death checkpoints, normally repress TNF cytotoxicity and therefore constitute crucial safeguards against these diseases. Death by TNF mainly proceeds upon inactivation of a checkpoint by microbial effector proteins or pathological mutations. We previously identified lysosomal turnover of TNFR1 Complex II by TAX1BP1-mediated selective macro-autophagy as a brake on TNF cytotoxicity. Here, we propose an alternative mechanism that prevents TNF-induced RIPK1 kinase-independent apoptosis. We found that inhibiting the ESCRT machinery, HSC70 or TAX1BP1 interferes with the TNF-dependent targeting of activated CASPASE-8 into endosomal intralumenal vesicles (ILVs) and is associated with apoptosis induction. Furthermore, we identified TAX1BP1 and TNFR1 Complex II components as TNF-induced cargoes of extracellular vesicles, suggesting that exosomal release of TNFR1 Complex II serves as a parallel detoxification pathway to lysosomal turnover. Finally, we show that Salmonella Typhimurium and Mycobacterium tuberculosis effector proteins activate TNF cytotoxicity by inhibiting components of the ESCRT machinery involved in this detoxification process.

Indexed as

Caspase 8ExosomesTumor Necrosis Factor-alphaAnimalsApoptosisEndosomal Sorting Complexes Required for TransportHumansMiceReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Tumor Necrosis Factor, Type ICaspase 8Endosomal Sorting Complexes Required for TransportReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Tumor Necrosis Factor, Type ITumor Necrosis Factor-alpha

Identifiers

PMID42786177
PMCPMC13612411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.